Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Johanna C. Bendell, MD
<< Back to Our Featured Experts
Dr. Bendell on the Next Steps Following Progression on Immunotherapy in MSI-H CRC
Dr. Bendell Discusses Pembrolizumab in CRC
Dr. Bendell on the Treatment of Microsatellite Stable Patients With CRC
Dr. Bendell on FDA Approval of Regorafenib in Liver Cancer
Dr. Bendell on Remaining Questions With Regorafenib in HCC
Dr. Bendell on Exciting Advancements in the Field of HCC
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Imad Tabbara, MD
Josep Tabernero, MD, PhD
Scott T. Tagawa, MD
Scott T. Tagawa, MD, MS
Julien Taieb, MD
Koichi Takahashi, MD
Mark S. Talamonti, MD
Robert L. Talley, MD
Martin S. Tallman, MD
Constantine S. Tam, MD
Winston Tan, MD
Samir Taneja, MD
Maki Tanioka, MD, PhD
Nizar M. Tannir, MD, FACP
Janos L. Tanyi, MD, PhD
William D. Tap, MD
Mary-Ellen Taplin, MD
Ahmad Tarhini, MD, PhD
Sarah K. Tasian, MD
Kurt Tauer, MD, FACP
Kurt W. Tauer, MD, FACP
Hussein A. Tawbi, MD, PhD
Alexandra Taylor, MD
Ayalew Tefferi, MD
Jennifer Temel, MD
Margaret A. Tempero, MD
Craig L. Tendler, MD
Rahul Tendulkar, MD
Masanori Terashima, MD, PhD, FACS
Welela Tereffe, MD
William P. Tew, MD
Krishnansu Tewari, MD
Premal H. Thaker, MD, MS
David D. Thiel, MD
James T. Thigpen, MD
Melanie B. Thomas, MD
Ian M. Thompson, MD
Michael A. Thompson, MD, PhD
Michael A. Thompson
Enrico Tiacci, MD
Raoul Tibes, MD, PhD
Cornelis M. van Tilburg, MD, PhD
Herve Tilly, MD, PhD
John M. Timmerman, MD
Brian A. Van Tine, MD, PhD
Vivianne Tjan-Heijnen, MD, PhD
Sara M. Tolaney, MD, MPH
Anthony W. Tolcher, MD
Kathleen Toomey, MD
Suzanne L. Topalian, MD
Max S. Topp, MD
Evanthia Roussos Torres, MD
Karim A. Touijer, MD
Danielle Townsley, MD
Edouard J. Trabulsi, MD
Edouard J. Trabulsi, MD, FACS
Tiffany A. Traina, MD
Jonathan C. Trent, MD
Jeffrey M. Trent, MD, PhD
Jonathan C. Trent, MD, PhD
Julia von Tresckow, MD
Frederic Triebel, MD, PhD
Carol Tringali, MS, RN
Debu Tripathy, MD
Domenico Trombetta, PhD
Judith Trotman, MBChB, FRACP
Judith Trotman, MD
Mark J. Truty, MD, MS
Apostolia Tsimberidou, MD, PhD
Apostolia M. Tsimberidou, MD, PhD
Nadine M. Tung, MD
Kiran K. Turaga, MD
Kiran Turaga, MD, MPH
Ismail Baris Turkbey, MD
Taylor Turner, MD
Nicholas Turner, PhD
Tim Turnham, PhD
Jonathan Tward, MD, PhD
Przemyslaw W. Twardowski, MD
Christopher Twelves, MD
Mark D. Tyson, MD
OncLive News Network On Location: ASH 2019 Day 3
Trending Now
Dr. Hurvitz on Using ADCs in HER2+ Breast Cancer
Residual Cancer Burden Predicts Patient Outcomes Across Breast Cancer Subtypes
Chemo-Free Regimen Matches Neoadjuvant Chemo in HR+/HER2- Breast Cancer
DLL3-Targeted and Chemo-Sensitive Therapy
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe